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Summary: In normal human kidney from adult males cytoplasmatic components which bound 17|3-oestradiol speci-
fically and with high affinity were demonstrated by dextran-coated charcoal assay, sucrose gradient centrifugation
and agar gel electrophoresis. The dissociation constant of the oestradiol-binder complex amounted to 2.2 ± 0.1 9
mol/1. The binding capacity was limited to 34.0 ± 9.7 fmol/mg of cytosol protein. Sedimentation in sucrose gradient
revealed the bulk of these components to be in the 4 S region. The binding entities could be clearly separated from
sex hormone-binding globulin by agar gel electrophoresis. The ligand specificity for binding to these components
indicated a requirement for oestrogens. The fact that an excess of aldosterone had no competitive effect on oestradiol
binding suggests that the oestrogen-binding sites are independent of mineralocorticoid receptors. It is concluded that
the specific binding components in human kidney have the properties of oestrogen receptors.
Identifizierung und teilweise Charakterisierung spezifisch östrogenbindender Komponenten in der menschlichen Niere
Zusammenfassung: In normalen menschlichen Nieren erwachsener männlicher Patienten wurden mittels Kohle-Adsorp-
tionstechnik, Sucrose-Dichtegradientenzentrifugation und Agargelelektrophorese zytoplasmatische Komponenten nach-
gewiesen, die 17j3-Östradiol spezifisch und mit hoher Affinität binden. Die Dissoziationskonstante des Östradiol-
Binderkomplexes betrug 2,2 ± 0,1 X l Cf9 mol/1. Die Bindungskapazität war begrenzt und belief sich auf 34,0 ± 9,7
fmol/mg Cytosolprotein. Bei der Sücrose-Dichtegradientenzentrifugation sedimentierte der größte Teil dieser Kompo-
nenten in der 4S-Region. Durch Agargelelektrophorese konnten diese Komponenten klar von sexualhormonbindendem
Globulin getrennt werden. In Kompetitionsexperimenten konnte gezeigt werden, daß diese Komponenten spezifisch
Östrogene binden. Da ein Überschuß an Aldosteron keinen kompetitiven Effekt auf die Bindung von 17/J-Östradiol hat,
sind die östrpgenbindenden Komponenten nicht mit Mineralcorticoidrezeptoren identisch. Die Untersuchungen zeigen,
daß die östrOgeribindenderi Komponenten die Eigenschaften von Östrpgenrezeptoren aufweisen.
Introduction
Although the kidney is not generally regarded as one
of the oestrogen target organs, the induction of hamster
kidney tumors by prolonged oestrogen administration
is well-known (1, 2). One of the reasons for the paucity
of information on the oestrogen responsiveness of
kidney is the former paradoxical failure to demonstrate
oestrogen receptors in normal hamster kidney (3).
However, there are some indications of oestradiol
binding to cytosol macromolecules and the nuclear
fraction of rat kidney (4, 5). Moreover, oestrogens have
been shown to decrease renal sodium excretion in adrenal-
ectomized rats (4), dogs (6), and normal humans (7).
These studies prompted an examination of normal
human kidney for oestrogen-binding components. A
partial characterisation of these binding sites is pre-
sented in this paper. Portions of these data have been
reported in a preliminary form (8).
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Materials and Methods
Chemicals and Reagents
[2,4,6,7-3H]oestradiol-170 (110 Ci/mmol) and Omnifluor
were purchased from New England Nuclear. Unlabelled hormones
were obtained from Calbiochem. Serva served as a source of
Norit A, while Dextran T 500 was purchased from Pharmacia.
Agar purum and bovine serum albumin were obtained from
Behring, Marburg. All other chemicals were commercial prepa-
rations of analytical grade.
SW56 titanium rotor. After centrifugation the bottom of the
tubes were pierced and six-drop fractions collected into scintil-
lation vials containing 2 ml of 99% ethanol. Ten milliliters of
toluene scintillation cocktail (4 g Omriifluor/1 toluene) were
added to each fraction and radioactivity was measured.
Protein Determination
Protein was estimated by Lowry's method (12), using bovine
serum albumin as standard.
Patients
Human kidney tissue used in our studies was obtained through
the cooperation of Dr. F. Boeminghaus, Urologische Klinik der
Universit t D sseldorf. In 1975 ten male patients, aged 49 to 79,
were nephrectomized because of renal cell carcinoma or other
reasons. As far as cancer kidneys were concerned, the carcinoma
was located only at the upper pole of the kidney. Specimens
were taken from those parts of the organ, which, by histological
examination, proved to be free of infiltrating cancer tissue.
Handling of Kidney Specimens
Immediately after nephrectomy, the kidney was perfused with
2 1 of ice-cold Ca-free Krebs-Ringer phosphate buffer, pH 7.4,
in vitro. Specimens of the blood-free kidney were decapsulated
and instantly immersed in liquid nitrogen.
Preparation of Kidney Cytosols
Kidney specimens (5—10 g), which had been stored in liquid
nitrogen prior to use, were placed in ice-cold Tris buffer A
(10 mmol/1 Tris-HCl, 1.5 mmoi/1 Na2EDTA, pH 7.4) or Tris
buffer B (10 mmol/1 Tris-HCl, 1.0 mmol/1 Na2EDTA, 0.25
mol/1 sucrose, pH 8.0) and allowed to stand at 3°C until thawed.
The samples were then minced roughly and stirred gently in the
same medium (1:10; w/v) for 10 min to ensure the removal of
serum contaminants. Subsequently, the washed tissue was
blotted and homogenized in a Dual! homogenizer with cold
Tris buffer A or B (1:3; w/v). Finally the homogenate was
centrifuged at 105 000 £ (3°C) for 30 min and the supernatant
(cytosol) removed without disturbing the iipid layer.
Dextran-Coated Charcoal Assay
This assay was a modification of the original method reported by
Korenman (9). Cytosols (0.2 ml portions), prepared in Tris buffer
B, were incubated with 0.2-4.0 nmol/1 [3H]oestradio 1-17/3 for
16 h at 0-3°C either alone or in the presence of unlabelled
competitive hormones at 1 μιηοΐ/l. Details of individual experi-
mental designs are given in the legends to figures and tables.
Following the incubation the samples were combined with 0.5 ml
of 5 g/i Norit A, 0.5 g/1 Dextran Τ 500, 10 mmol/l Tris-HCl,
1 mmol/1 Na2 EDTA, 0.25 mol/1 sucrose at pH 8.0. The mixture
was incubated at 0-3°C for 5 min and then centrifuged at
12 000 rev./min for 2 min in an Eppendorf centrifuge, model
3200. Portions (0.2 ml) of the supernatant fluid were transferred
into scintillation vials containing 10 ml of Bray's scintillation
fluor (10) for counting in a liquid scintillation counting system.
Sucrose Gradient Assay
The assay procedure closely paralleled that originally described
by Toft & Gorski (11). Briefly, aliquots (200 μΐ) of cytosol
prepared in Tris buffer A were reacted with [3HJocstradio 1-170
for 2 h at 0-3°C, either alone or in the presence of unlabelled
competitive hormones at 1 μιηοΐ/ΐ. Portions (500 μΐ) of 5 g/1
Norit A, 0.5 g/1 Dextran t 500,10 mmol/1 Tris-HCl, 1.5 mmol/1
Na2EDTA at pH 7.4 were centrifuged 2 min at 12 000 rev./min
in an Eppendorf centrifuge. The supernatants were discarded. The
labelled cytosols were then mixed with the charcoal pellets and
processed as described under dextran^coated charcoal assay. The
supernatant fluids were assayed for receptor activity by layering
over linear 50-200 g/1 sucrose gradients in Tris buffer A. These
gradients were centrifuged in a Beckman L2-65B preparative
ultracentrifuge for 16 h at 56 000 rev./min (0°C), using a Spinco
Agar Gel Electrophoresis
Electrophoresis closely paralleled that originally described by
Wagner (13). Briefly, kidney specimens (1-2 g), which had been
stored in liquid nitrogen, were pulverized in three volumes of
Tris buffer C (10 mmol/1 Tris-HCl, 1.0 mmol/l NaN3, pH 7.5) in
a mortar chilled with liquid nitrogen. The powder was allowed
to thaw at 4 °C. Subsequently, the thawed homogenate was
centrifuged at 105 000 £ (3°Q for 30 min in order to prepare the
cytosol. Cytosols (0.2 ml portions) were incubated for 2 h at
0-3°C with 2 nmol/1 [3Hjoestradiol-17/3 either alone or in the
presence of unlabelled competitive hormones at 1 μηιοΐ/ΐ.
Following the incubation, 50 μΐ portions of the cytosols were
placed into each of the 10 sample wells punched at the centre
line of the agar slab. During electrophoresis (130 mA, 70 rnin)
the temperature in the receptor region of the gel was con-
tinuously monitored by an epoxycpated extra small thermistor
(Yellow Springs instrument Co., part 44202) and maintained at
3-4°C by cooling of the teflon^coated brass block. After the run,
the individual analyses were separated by lengthwise slicing the
gel slab. Subsequently, the strips were cut into 0.5 cm sections,
using a razor blade. The samples were placed into wire-gauze
baskets coated with a thin layer of black paper. The strips were
dried at 60°C for 12 h. Using special sample holders attached to
screw caps (BF-Vertriebs GmbH far Me technik, Karlsruhe), the
baskets were placed into glass scintillation counting vials, con-
taining 0.5 ml of distilled water. With the aid of a simple device,
up to 40 vials were evacuated and filled with oxygen (14). The
screw caps were then sealed gas-tight, and automatic in-vial
combustion started using the Micro-Mat BF 5010 (BF^Vertriebs
GmbH). This procedure is a modification of the technique
originally described by Gupta (15). When combustion of the
samples was complete the vials were allowed to stand at - 10°C
for about 5 min in order to completely condense the tritium
water-vapor. The special sample holders were removed, 10 ml
of Bray''s scintillation fluor (10) was added to each vial, the
samples being ready for liquid scintillation counting.
Results
Use of the Dextran-Coated Charcoal Assay
The charcoal adsorption assay was used to estimate the
affinity of the binding components for 17j3-oestradipl and
to determine the ligand specificity of oestradiol binding
to these components.
Titration of the cytosol with 17 -oestradiol
To ascertain the affinity of the cy toplasmic binder for
the hormone, a constant volume of cytosol from human
kidney was titrated with increasing concentrations of
[3H]oestradioM7|3. Parallel titrations in the presence of
an excess of unlabelled hormone allowed the correction
of the binding data for non-specific binding. Using the
method ofScatchard (16), a typical analysis of the
titration data shown in Figure 1 resulted in a straight line.
From the slope of the Scatchard plot the dissociation
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Tab. 1. Ligand specificity of (3H)oestradiol-17/3 binding assessed
by dextran-coated charcoal assay and agar gel electrophor-
esis of cytosol from human kidney.
Dextran-coatcd charcoal assay - Cytosols (0.2 ml por-
tions) prepared in Tris buffer B were incubated with
3.7 nmpl/1 [3H]oestradiol-170 for 16 h at 0-3°C either
alone or in the presence of a competitive substance at
1 Mmol/1. Each reaction was terminated by the addition
of 0.5 ml of the dextran-coated charcoal reagent.
Agar gel clectrophoresis - Aliquots (0.2 ml) of cytosol,
prepared in Tris buffer C, were incubated with 2 nmol/1
[3H]oestradiol-170 for 2 h at 0-3°C, either alone or in the
presence of unlabclled hormones at 1 jumol/1. Conditions
of agar gel electrophoresis: 50 jul portions of reacted cytosol
applied to 10 g/1 agar gel, 130 mA, 70 min, 3-4°C (gel
temperature in receptor region), 5 mm sections counted
after in-vial combustion.
Inhibition of specific |3H|oestradiol-17/3 binding is ex-





Fig. 1. Scatchard analysis of titration data for the oestrogen-
binding components in the cytosol of human kidney.
Cytosols (0.2 ml portions) prepared in Tris buffer B
were incubated with increasing concentrations of
[3H]oestradiol-170 (0.2-3.7 nmol/1) at 0-3°Cfor 16 h
either alone or in the presence of unlabelled oestradiol
at 1 μπιοΐ/ΐ. Binding was measured by dextran-coated
charcoal assay. Kj = 2.2 -10"9 mo 1/1.
constant (K^) of the binderJigand complex was calculated
and found to be 2.2 ± 0.1 X 10~9 mol/1 (mean ± SEM of
five individual experiments). The concentration of binding
sites, assuming that each site binds only one molecule of
17j3-oestradiol and that only a single class of binding
entities exists, amounted to 34.0 ± 9.7 fmol/mg of
cytosol protein (mean ± SEM of five individual experi-
ments), ranging from 10 to 60 fmol/mg of protein.
Ligand specificity
•The relative affinities of several steroid hormones for
the 17j3-oestradiol binding components, as measured
by competition studies, are summarized in Table 1. The
ligand specificity for binding to these sites clearly indicated
a requirement for oestfogens. The binding of tritiated
17/3-oestradiol was inhibited by unlabelled 17/k>estradiol
as well as by oestrone and oestriol. Aldosterone and
cortexolone were only insignificantly competitive with
17/^oestradiol for binding sites in human kidney cytosol.
AH other steroids tested were not competitive.
Sucrose Gradient Cen^trifugation
Sedimentation patterns of the 170-oestradiol binding
entities of human kidney cytosol on sucrose density
gradients are shown in Figure 2. Specific binding is in-



































dicated by the difference in the areas under the peaks,
obtained in the absence (closed circles) or presence
(open circles) of an excess of unlabelled 17j3-oestra-
diol. Analysing the cytosols from kidneys of different
patients, two distinct types of isotopic profiles were
obtained. In both plots (Figure 2, profile A and profile B)
specific binding of 17j3-oestradiol to a macromolecular
component, sedimeriting in the 4 S region of the gradient,
could be detected. However, in profile A, additional
specific binding entities at about 3 S and 6 S were
discernible. Moreover, a significant fraction of the radio-
activity was recovered at the bottom of the centrifuge
tube, thus showing a considerable higher sedimentation
coefficient. It therefore appears that in some cases at low
salt concentration 170-oestradiol forms a complex with
cytosol macromolecules which tend to aggregate:
Agar Gel Electrophoresis
In order to more closely characterize the oestrogen
binding components in human kidney, the cytosol was
applied to agar gel electrophoresis at low temperature.
The assay discriminates between receptor proteins and
sex hormone-binding globulin which might be present in
human tissue extracts due to serum contamination (13).
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Fig. 2. Two representative types of isotopic profiles of oestrogen-binding components separated by sucrose gradient centrifugation of
cytosols obtained from human kidneys. Aliquots (0.2 ml) of cytosol prepared in Tris buffer A were incubated in vitro with
3 nmol/1 [3H]oestradiol-170 for 2 h at 0-3°C, either alone (closed circles) or in the presence of unlabelled 170-oestradiol at
1 Mmol/l (open circles). The cytosols were subjected to dextran-coated charcoal treatment and then assayed for binding activity
by layering over linear 50-200 g/1 sucrose gradients in Tris buffer A. The gradients were centrifuged for 16 h at 56.000 rev./min
(0°C), using a Spinco SW 56 rotor.
Isotopic profiles of the oestrogen binding entities separ-
ated by agar gel electrophoresis of human kidney cytosol
are shown in Figure, 3. As estimated by the difference
between the isotopic profiles of total (open circles) and
non-specific binding (closed circles) specific binding of
[3H]oestradiol-17j3 could be demonstrated in the receptor
region of the gel. No appreciable amounts of sex hormone-
binding globulin which migrates towards the cathode are
to be seen in this plot. The ligand specificity of [3H]oestra-
diol-170 binding in the receptor region, as measured by
competition studies in the presence of a hundred-fold
excess of unlabelled hormone is summarized in Table 1.
The results are very similar to those assessed by the
dextran-coated charcoal procedure. The ligand specificity
for binding to molecules in the receptor region indicated
a stringent requirement for oestrogens. Essentially no in-
hibition of [3H]oestradiol-170 binding was observed in the
presence of all other steroid hormones tested.
Discussion
Evidence was obtained for the existence of specific
binding sites for oestrogens in human kidney cytosol.
The fact that unlabelled aldosterone did not significantly
compete with tritiated 170-oestradiol for binding to these
entities indicates that the oestrogen-binding sites are in-
dependent of mineralocorticoid receptors. These findings
are supported by similar observations of the ligand speci-
ficity of oestradiol binding by rat kidney cytosol (4, 5).
The inability of dihydrotestosterone and glucocorticoid
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Fig. 3. Isotopic patterns of oestrogen-binding components sepa-
rated by agar gel electrophoresis of cytosols obtained from
human kidney. Cytosols (0.2 ml) prepared in Tris buffer C
were reacted in vitro with 2 nmol/1 (3HJoestradio 1-170
for 2 h at 0-3°C, either alone (open circles) or in the
° presence of a 100-fold excess of unlabelled 170-oestradiol
(closed circles). Conditions of agar gel electrophoresis:
50 μΐ portions of labelled cytosol applied to 10 g/1 agar
gel, 130 mA, 70 min, 3-4°C (gel temperature in receptor
region), 5 mm sections counted after in-vial combustion.
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these sites, suggests that the oestrogen-binding compo-
nents are not identical with androgen or glucocorticoid
receptors which have been demonstrated in the kidney of
mice (17) and rats (18), respectively. The observation
that the binding of oestradiol was unaffected by
testosterone (Table 1) made it unlikely that the binding
entities were identical with sex hormone-binding globulin
which is known to have a high affinity for testosterone
(19). Moreover, by agar gel electrophoresis (Fig. 3) it
could be clearly demonstrated that the oestrogen binding
components from human kidney cytosol exhibited an
electrophoretic mobility which was different from that
of sex hormone-binding globulin and which closely re-
sembled that of oestrogen receptors in calf uteri (13). The
binding reaction displayed saturation kinetics and high
affinity binding of 170-oestradiol to cytosol macromole-
cules. Presumptive evidence exists that these high affinity
— low capacity sites are most likely to represent receptor
complexes from different organs have been found to be
in the range of 10'12 to 10~9 mol/1 (4, 20, 21, 22), but
widely varying experimental conditions make quantita-
tive comparisons of little value. However, the dissociation
constant of the high affinity binder-ligand complex from
human kidney cytosol (~ 2 X 10~9 mol/1) is strikingly
similar to that of rat kidney (~ 3 X 10"10 - 1 X 10"9
mol/1), rat mammary gland (~ 8 X 10"10 mol/1), R3230AC
mammary adenocarcinoma (~ 1.2 X 10~9 mol/1), human
breast carcinoma (~ 9 X ICf10 mol/1) and human renal
cell carcinoma (~ 3 X 10"9mol/1) found in our labora-
tories (5, 21, 22,-23). The number of high affinity binding
sites of human kidney cytosol (~ 34 fmol/mg cytosol
protein) compares well with that of rat kidney (~ 50 fmol/
mg) (4) and lactating mammary gland of the rat (~ 15—50
fmol/mg) (21),
Interestingly, the binding capacity of cytosol prepared
from different kidney specimens varied considerably
(10-60 fmol/mg of protein), although the dissociation
constant of the oestradiol-binder complex remained
nearly constant. It is supposed that the oestrogen-binding
components of human kidney are not evenly distributed
among medulla and cortex. Experiments to determine
the distribution of these binding sites are in progress.
However, according to preliminary results, the oestradiol-
binding sites are found predominantly in the kidney
medulla.
By sucrose gradient analysis, two distinct types of sedi-
mentation behaviour were demonstrated (Fig. 2). In
both profiles, sedimentation of the binder-ligand complex
at about 4S was observed, which closely resembles that
of unactivated oestradiol receptor complexes in various
target organs. Whether the 3.0-3.1 S peak in profile A
(Fig. 2) represents binding to precursors (3.5 S) of the
oestrogen receptors (24) remains to be elucidated. So far,
no definite explanation can be provided for the absence
of high molecular weight aggregates in some sucrose
gradient analyses. The finding of oestrogen receptors in
human kidney raises the question about their physio-
logical significance. At present, oestrogens seem to be
involved in the regulation of renal sodium excretion in
various species, including man (4, 6, 7). Moreover, studies
of our own laboratory indicate that 17/J-oestradiol stimul-
ates protein synthesis in enzymatically isolated kidney
tubules of rat and man (23).
Acknowledgements
This investigation was supported by the Minister für Wissenschaft
und Forschung des Landes Nordrhein-Westfalen.
References
1. Kirkman, H. (1959), Nat. Cancer Inst. Monogr. l, 1-59.
2. Steggles, A. W. & King, R. J. B. (1968), Europ. J. Cancer 4,
395-401.
3. Steggles, A. W. & King, R. J. B. (1972), Europ. J. Cancer 8,
323-334.
4. De Vries, J. R., Ludens, J. H, & Fanestiel, D. D. (1972),
Kidney International 2, 95-100.
5. Bojar, H., Wittliff, J. L., Balzer, K., Dreyfürst, R. & Staib, W.
(1974), Hoppe-Seyler's Z. Physiol. Chem. 355,1181.
6. Johnson, J. A., Davis, J. O., Baumber, J. S. & Schneider, E. G.
(1970), Am. J. Physiol. 279, 691-1697.
7. Preedy, J. R. K. & Aitken, E. H. (1956), J. Clin. Invest. 35,
423-429.
8. Bojar, H., Wittliff, J. L., Balzer, K., Dreyfürst, R., Boeming-
haus, F. & Staib, W. (1975), Acta Endocf. (Kbh) Suppl. 193,
51.
9. Korenman, S. G. (1968), J. Clin. Endocrinol. Metab. 28,
127-130.
10. Bray, G. A. (1961), Anal. Biochem. /, 279-285.
11. Toft, D. & Gorski, J. (1966), Proc. Nat. Acad. Sei. U.S. 55,
1574-1581.
12. Lowry, Ö. H., Rosebrough, A. L., Farr, A. L. & Randall, R. J.
(1951), J. Biol. Chem. 193, 265-275.
13. Wagner, R. K. (1972), Hoppe-Seyler's Z. Physiol. Chem. 353,
1235-1245.
14. Wegner, L. A. & Winkelmann, H. (1970), Atompraxis 16,
19-26.
15. Gupta, G. N. (1966), Analyt. Chem. 38,1356-1359.
16. Scatchard, G. (1949), Ann. N. . Acad. Sei. 57, 660-672.
17. Drews, U., Itakura, H., Dofuku, R., Tettenborn, U. & Ohno, S.
(1972), Nature New Biol. 238, 216-217.
18. Rafestin-Oblin, M. E., Michaud, A. & Corvol, P. (1975), 10th
Meeting Federation of European Biochemical Societies,
Abstract No. 1376.
19. Westphal, U. (1971), Steroid-Protein Interactions (Gross, F.,
Labhart, ., Mann, T., Samuels, L. T. & Zander, J., eds.)
pp. 356-374, Springer-Verlag, Berlin, Heidelberg, New York.
20. Hähnel, R. (1971), Steroids 77, 105-132.
J. Clin. Chem. Clin. Biochem. / Vol. 14, 1976 / No. 11
520 Bojar, Balzer, Dreyfürst, Staib and Wittliff: Identification of oestrogen receptor in human kidney
21. Wittliff, J. L., Gardner, D. G., Battema, W. L. & Gilbert, P. J. 23. Bojar, H., Dreyfiirst, R., Balzer, K., Döscher, D. & Staib, W.
(1972), Biochim. Biophys. Res. Cominun. 48,119-125. (1975), Acta Endocr. (Kbru) Suppl. 199, 130.
22. Wittliff, J. L., Hilf, R., Brooks, W. F., Savlov, E. D., Hall, T. C 24. Little, M., Szendro, P. I. & Jungblut, P. W. (1973), Hoppe-
& Orlando, R. A. (1972), Cancer Res. 32, 1983-1992. Seyler's Z. Physiol. Chem. 354, 1599-1610.
Dr. Hans Bojar




J. Clin. Chem. Clin. Biochem. / Vol. 14, 1976 / No. 11
